Reneo Pharmaceuticals, Inc.

The momentum for this stock is not very good. Reneo Pharmaceuticals, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Reneo Pharmaceuticals, Inc..
Log in to see more information.

News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VAPO, SGE, RPHM, SQSP on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VAPO, SGE, RPHM, SQSP on Behalf of Shareholders

PR Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VAPO, SGE, RPHM, SQSP on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VAPO, SGE, RPHM, SQSP on Behalf of...\n more…

RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM
RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM

Business Wire Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Reneo Pharmaceuticals, Inc. (NasdaqGM: RPHM...\n more…

Braden Michael Leonard Acquires 171,339 Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Stock
Braden Michael Leonard Acquires 171,339 Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Stock

Zolmax Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM - Get Free Report) major shareholder Braden Michael Leonard purchased 171,339 shares of the stock in a transaction that occurred on Tuesday, August 13th. The...\n more…

Video: Thursday 8/15 Insider Buying Report: RPHM, PEB
Video: Thursday 8/15 Insider Buying Report: RPHM, PEB

Market News Video Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their...\n more…

RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q2 2024
RPHM Stock Earnings: Reneo Pharmaceuticals Misses EPS for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nRPHM stock results show that Reneo Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.\nThe post...\n more…

Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results

Globe Newswire IRVINE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a pharmaceutical company historically focused on the development and commercialization of therapies for...\n more…